Priority topics

Areas covered will include:

• Emerging exercise testing and rehabilitation modalities for chronic lung disease
• Pulmonary rehabilitation beyond COPD
• Vaping and lung health: what you need to know?
• Integration of care pathways: telehealth to optimise monitoring and care of chronic respiratory diseases
• Interprofessional collaboration and patient empowerment in pulmonary rehabilitation

Areas covered will include:

• Reducing the environmental footprint of respiratory support
• Remote care for patients on assisted breathing
• Sleep-disordered breathing in different diseases: from obesity to COPD or neuromuscular diseases
• Sputum mobilisation in lung diseases and neuromuscular diseases
• Acute exacerbation of COPD: current treatment and future perspectives

Areas covered will include:

• Basic science on lung diseases
• Use of patient derived organoids for drug screening and cell-based strategies
• Spatial multimodal omics and AI to understand, early diagnose and predict lung diseases
• The role of the inflammatory and fibrotic microenvironment in modulating stem/progenitor cell fate and function
• iPSCs and disease modelling

Areas covered will include:

• New CPAP guidelines for OSA a phenotype- and outcome-oriented approach
• New era of pharmacotherapy for sleep-disordered breathing
• Respiratory sleep medicine meets cardiology
• Uncontrolled obstructive airway disease – is OSA the missing link?
• Awareness and screening strategies for SDB in primary care

Areas covered will include:

• Airway diseases target beyond T2
• New biologics for COPD
• Early originated COPD, PPD, small lungs and chronic cough
• AI in airway diseases, the future is here
• New biologics and biosimilars for asthma

Areas covered will include:

• The impact of environmental and occupational exposures on lung health and disease
• The triple planetary crisis – air pollution, biodiversity loss and climate change – in relation to respiratory health
• Lung trajectories and lifetime exposures and disease development across the globe
• Primary prevention in respiratory health: lifestyle changes to avoid disease
• Designing healthy cities: multidisciplinary approaches for improved respiratory health
• Translational epidemiology: potential for transfer of knowledge from epidemiology to bedside and improved public health

Areas covered will include:

• Small airway diseases
• Chronic cough in a lifetime
• Biologics in children with severe asthma: how to choose and how to stop
• Long-term outcomes of congenital airway and lung malformations
• Vaping epidemics in children and adolescents

Areas covered will include:

• Surgery for empysema: when, who and how
• GGO beyond lung cancer: what we know about
• Let’s speak about: antibodies and lung
• Preoperative immunotherapy for lung cancer: state-of-the-art and future direction
• Modern treatment of secondary tumour to the pleura

Areas covered will include:

• Exercise to maintain health/prevent comorbidities
• Patient-centred approach of self-management skills
• Innovation in testing and exercise training
• Novel approaches to adherence and behaviour change
• Relapse prevention: sustaining self-management
• Patient involvement/empowerment: Co-creating, listening and discovering together

Areas covered will include:

• Non-antibiotic approach of respiratory infections
• Antimicrobial resistance
• Improving NTM management
• Post TB lung disease
• Role of lifetime vaccination

Areas covered will include:

• New TNM staging in lung cancer and re-evaluation of surgical resection parameters
• Lung cancer screening and implications for services
• The evolving role of liquid biopsy in thoracic oncology
• Patient re-assessment after neoadjuvant treatment
• Living guidelines in lung cancer, malignant pleural effusion and mesothelioma

Areas covered will include:

• Pulmonary complications of CTDs
• Pneumoconiosis and sarcoidosis
• ILA – navigating the shadow of grey
• IPF and lung cancer
• Fibrosis across organ systems

Areas covered will include:

• Drug development
• CTEPH: controversies in the management
• Controversies in the management of the intermediate-high and high risk PE
• Comorbidities
• Lung manifastations of connective tissue disorders

Areas covered will include:

• Peripheral pulmonary nodules
• Use of AI
• Imaging of the airway
• Ultrasound guided procedures
• How to use current equipment today
• Lung cancer screening